AMBQ Ambiq Micro, Inc.
Semiconductors & Related Devices · NYSE · SEC CIK 1500412 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY63.4%
TTM net income YoY2.6%
TTM EPS YoY100.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin44.8%
Operating margin-36.0%
Net margin-29.7%
FCF margin—
EBITDA margin-30.1%
Returns
ROE-12.2%
ROA-11.3%
ROIC (approx.)-102.7%
Asset turnover0.38x
Leverage & solvency
Liabilities / assets6.8%
Debt / equity0.00x
Current ratio16.55x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.84x
Accruals ratio-1.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $38.14M | $33.90M | $25.06M | $20.74M | $18.16M | $17.87M | $15.73M | $20.34M |
| Cost of revenue | $20.32M | $18.63M | $14.17M | $11.88M | $10.49M | $10.70M | $7.34M | $15.29M |
| Gross profit | $17.82M | $15.27M | $10.89M | $8.86M | $7.68M | $7.17M | $8.39M | $5.05M |
| R&D expense | $16.30M | $14.14M | $12.83M | $12.01M | $8.89M | $8.90M | $8.69M | $8.77M |
| SG&A expense | $11.55M | $9.86M | $9.75M | $8.81M | $8.83M | $7.07M | $8.44M | $6.65M |
| Operating income | -$10.03M | -$8.73M | -$11.69M | -$11.96M | -$10.04M | -$8.80M | -$8.74M | -$10.37M |
| Pretax income | -$7.05M | -$7.11M | -$10.17M | -$10.66M | -$9.00M | -$8.48M | -$8.28M | -$10.19M |
| Income tax | $4,000 | $1,000 | $3,000 | $19,000 | $3,000 | $14,000 | $4,000 | $3,000 |
| Net income | -$7.06M | -$7.12M | -$10.17M | -$10.68M | -$9.00M | -$8.50M | -$8.28M | -$10.19M |
| EBITDA | -$8.21M | -$6.94M | -$9.95M | -$10.31M | -$8.29M | -$6.94M | -$6.78M | -$8.76M |
| EPS (basic) | -0.29 | -0.32 | -0.50 | — | -0.72 | -18.89 | -18.96 | — |
| EPS (diluted) | -0.29 | -0.32 | -0.50 | — | -0.72 | -18.89 | -18.96 | — |
| Weighted avg. shares (diluted) | 24.27M | 21.74M | 20.40M | — | 12.46M | 449,785 | 436,890 | — |
| Balance sheet | ||||||||
| Cash & equivalents | $363.45M | $366.77M | $204.53M | $140.28M | $146.49M | $47.51M | — | $60.98M |
| Receivables | $19.02M | $17.53M | $10.97M | $7.29M | $7.01M | $7.79M | — | $10.40M |
| Inventory | $30.05M | $29.36M | $23.46M | $16.94M | $16.13M | $15.76M | — | $15.01M |
| Current assets | $417.32M | $416.62M | $241.66M | $167.92M | $173.02M | $74.89M | — | $88.96M |
| PP&E, net | $4.50M | $4.33M | $4.32M | $4.14M | $4.35M | $4.00M | — | $2.62M |
| Intangibles | — | — | — | $11.59M | — | — | — | $11.73M |
| Total assets | $434.89M | $435.62M | $259.52M | $184.68M | $186.73M | $89.16M | — | $104.28M |
| Current liabilities | $25.22M | $26.12M | $20.65M | $19.18M | $13.27M | $13.36M | — | $11.77M |
| Total liabilities | $29.52M | $30.95M | $24.36M | $22.22M | $16.94M | $18.32M | — | $18.53M |
| Shareholders' equity | $405.38M | $404.67M | $235.16M | $162.46M | $169.79M | -$307.31M | -$299.72M | -$292.40M |
| Shares outstanding | 24.52M | 24.15M | 21.36M | 18.32M | 18.24M | 450,682 | — | 434,720 |
| Cash flow statement | ||||||||
| Operating cash flow | -$4.70M | -$9.51M | -$11.17M | -$4.11M | -$5.03M | -$11.96M | $1.41M | $276,000 |
| Investing cash flow | -$1.78M | -$1.88M | -$4.02M | -$2.59M | -$1.71M | -$2.02M | -$1.12M | -$1.34M |
| Financing cash flow | $3.15M | $173.59M | $79.44M | $486,000 | $105.72M | $27,000 | $148,000 | $511,000 |
| Depreciation & amortization | $1.81M | $1.78M | $1.74M | $1.65M | $1.75M | $1.85M | $1.96M | $1.61M |
| Stock-based compensation | $4.02M | $3.56M | $3.36M | $3.15M | $2.07M | $765,000 | $851,000 | $863,000 |
Free plan shows the latest 8 periods; Pro shows all 10 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.